Dr. Newcomer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7205 Corporate Center Drive
Miami, FL 33126
Summary
- John W. Newcomer, M.D. is President and CEO of Thriving Mind South Florida (contracting as South Florida Behavioral Health Network, Inc.), the non-profit organization that oversees safety net mental health and substance abuse services for Miami-Dade and Monroe counties, with annual funding of over $110 million from Florida's Department of Children and Families as well as other federal, state, local and private sources. Dr. Newcomer is also an Adjunct Professor of Psychiatry at Washington University School of Medicine in St. Louis. He previously served as Vice Dean for the medical school at Florida Atlantic University, and prior to that was Senior Associate Dean for Clinical Research at the University of Miami Miller School of Medicine. During more than two decades at Washington University, he served in leadership positions related to the National Institutes of Health (NIH) funded General Clinical Research Center, the Clinical Translational Science Award and the Center for Clinical Studies. Dr. Newcomer has been a Principal Investigator on grants funded through the National Institutes of Health (NIH) and the Substance Abuse and Mental Health Services Administration (SAMHSA) for almost 30 years. In the public sector he was Chair of the Medicaid Drug Utilization Review Board for the State of Missouri for 13 years which provided public oversight for a >$1.2 billion pharmacy budget. In 2014 he was named to the Thomson Reuters List of Highly Cited Researchers in the field of Psychiatry.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1986 - 1989
- Mount Sinai Medical Center of FloridaInternship, Internal Medicine, 1985 - 1986
- Wayne State University School of MedicineClass of 1985, MD, Alpha Omega Alpha
- Brown UniversityAB, Philosophy of Science, Phi Beta Kappa, 1977 - 1981
Certifications & Licensure
- FL State Medical License 2011 - 2026
- CA State Medical License 1986 - 2020
- MO State Medical License 1990 - 2019
- MI State Medical License Active through 1986
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Thomson Reuters List of Highly Cited Researchers 2014
Clinical Trials
- Glucose Regulation During Risperidone and Olanzapine Treatment
- Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Start of enrollment: 2005 Feb 01
- Metabolic Effects of Antipsychotics in Children Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1477 citationsPhysical illness in patients with severe mental disorders.I. Prevalence, impact of medications and disparities in health careMarc De Hert, Christoph U. Correll, Julio Bobes, Marcelo Cetkovich-Bakmas, Dan Cohen
World Psychiatry. 2011-02-01 - 45 citationsA 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, queti...John W. Newcomer, Robert E. Ratner, Jan W. Eriksson, Robin Emsley, D. Meulien
The Journal of Clinical Psychiatry. 2009-04-07 - 23 citationsA post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus halop...Stephen M. Stahl, Ashok Malla, John W. Newcomer, Steven G. Potkin, Peter J. Weiden
Journal of Clinical Psychopharmacology. 2010-08-01
Journal Articles
- Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People with Severe Mental IllnessChristina V Mangurian, Dean Schillinger, John W Newcomer, Diabetes Care
- Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People with Severe Mental IllnessChristina V. Mangurian, John W. Newcomer, Diabetes Care
Press Mentions
- She Went from a ‘Dark Period’ in High School to Preaching About Suicide PreventionMarch 10th, 2023
- Round-the-Clock Mental-Health Services Available for Those Touched by Surfside Collapse | OpinionJuly 20th, 2021
- The Overlooked Opioid Crisis in Latinx CommunitiesMarch 2nd, 2020
- Join now to see all
Grant Support
- Cooperative Agreement for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional DisturbancesSAMHSA2018–2022
- Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Early Serious Mental Illness: iOTA-eSMINIMH2019–2021
- Metabolic Effects Of Antipsychotics In ChildrenNational Institute Of Mental Health2006–2010
- Metabolic Effects Of Antipsychotics In ChildrenNational Center For Research Resources2006–2007
- Aripiprazole IvgttNational Center For Research Resources2006–2007
- Glucose And Lipid Metabolism On Antipsychotic MedicationNational Center For Research Resources2005–2007
- Glucocorticoid Regulation Of Memory Performance In Aging HumansNational Center For Research Resources2005–2007
- Kids KetamineNational Center For Research Resources2004–2007
- A Pilot Study Of Metabolic Effect Of Antipsychotics In ChildrenNational Center For Research Resources2005–2006
- Glucose Regulation During Risperidone And Olanzapine TreatmentNational Center For Research Resources2005
- Antipsychotic MedicationNational Institute Of Mental Health2001–2005
- Glucose Regulation During Risperidone And Olanzapine Treatment.National Center For Research Resources2004
- Glucose And Lipid Metabolism On Antipsychotic Medication.National Center For Research Resources2004
- Glucocorticoid Regulation Of Memory Performance In Aging Humans.National Center For Research Resources2004
- Glucocorticoid Regulation Of Memory In Aging HumansNational Institute Of Mental Health2000–2003
- Glucose Enhancement Of Memory/Attention In SchizophreniaNational Center For Research Resources2000–2002
- Glucocorticoid Regulation Of Memory Performance In AgingNational Center For Research Resources2000–2002
- Neuroendocrinology Of Memory And Aging In SchizophreniaNational Center For Research Resources1999–2002
- Preventing Nrh Induced Symptoms In HumansNational Center For Research Resources1998–2002
- Neurochemical Control Of Memory In Aging SchizophrenicsNational Institute Of Mental Health1997–2001
- Leptin And Weight Loss In Major Depressive DisorderNational Center For Research Resources1999
- Insulin Regulation Of Memory Performance During Normal AgingNational Center For Research Resources1997–1999
- Cognitive And Behavioral Effects Of Subanesthetic Doses Of KetamineNational Center For Research Resources1996–1999
- Accelerated Hippocampal Aging In SchizophreniaNational Center For Research Resources1996–1999
- Neuroendocrinology Of Memory And Aging In SchizophreniaNational Institute Of Mental Health1996–1998
- Effects Of Cortisol On Cognitive Performance In Aging HumansNational Center For Research Resources1996–1997
- Accelerated Hippocampal Aging In Schizophrenia PatientsNational Institute Of Mental Health1992–1996
Professional Memberships
- Member
- American College of NeuropsychopharmacologyFellow
- Distinguished Fellow
- American College of PsychiatristsMember
- Society for NeuroscienceMember
- Member
- Member
External Links
- FAU Schmidt College of Medicine Researchhttp://med.fau.edu/research/about.php
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: